• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典一个患有I型假性醛固酮增多症(PHA1)的家族中,盐皮质激素受体基因出现一种新的无义突变。

A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).

作者信息

Nyström A-M, Bondeson M-L, Skanke N, Mårtensson J, Strömberg B, Gustafsson J, Annerén G

机构信息

Department of Genetics and Pathology, Uppsala University, S-751 85 Uppsala, Sweden.

出版信息

J Clin Endocrinol Metab. 2004 Jan;89(1):227-31. doi: 10.1210/jc.2003-030762.

DOI:10.1210/jc.2003-030762
PMID:14715854
Abstract

Pseudohypoaldosteronism type I (PHA1) is a condition associated with salt wasting leading to dehydration, hypotension, hyperkalemia, and metabolic acidosis. Sporadic cases and two familial forms, one autosomal dominant and one autosomal recessive form, have been described. The autosomal dominant or sporadic form manifests milder salt wasting that remits with age. Mutations in the gene encoding the mineralocorticoid receptor (MR) have been identified in patients with the autosomal dominant inheritance. However, recent studies suggest that the autosomal dominant and sporadic forms are genetically heterogeneous and that additional genes might be involved. We report on the study of 15 members of a Swedish five-generation family with the autosomal dominant form of PHA1. Interestingly, neuropathy was found in two of five affected individuals. A novel heterozygous nonsense mutation C436X in exon 2 was identified in the index patient by linkage analysis, PCR, and direct sequencing of the MR gene. Analysis of the family demonstrated that the mutation segregated with PHA1 in the family. It is unclear whether the neuropathy is associated with the mutation found. Our results together with previously published data suggest that loss-of-function mutations of the MR gene located at 4q31.1, commonly are associated with the autosomal dominant form of PHA1.

摘要

I型假性醛固酮增多症(PHA1)是一种与失盐相关的疾病,可导致脱水、低血压、高钾血症和代谢性酸中毒。已报道过散发病例以及两种家族性形式,一种为常染色体显性遗传,另一种为常染色体隐性遗传。常染色体显性或散发性形式表现为较轻的失盐,随年龄增长可缓解。在常染色体显性遗传患者中已鉴定出编码盐皮质激素受体(MR)的基因突变。然而,最近的研究表明,常染色体显性和散发性形式在遗传上是异质性的,可能涉及其他基因。我们报告了对一个瑞典五代家族中15名患有常染色体显性形式PHA1的成员的研究。有趣的是,在五名受影响个体中的两名发现了神经病变。通过连锁分析、PCR和MR基因直接测序,在索引患者中鉴定出一个位于外显子2的新型杂合性无义突变C436X。对该家族的分析表明,该突变与家族中的PHA1共分离。尚不清楚神经病变是否与所发现的突变有关。我们的结果与先前发表的数据共同表明,位于4q31.1的MR基因功能丧失突变通常与PHA1的常染色体显性形式相关。

相似文献

1
A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).瑞典一个患有I型假性醛固酮增多症(PHA1)的家族中,盐皮质激素受体基因出现一种新的无义突变。
J Clin Endocrinol Metab. 2004 Jan;89(1):227-31. doi: 10.1210/jc.2003-030762.
2
A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.一个患有1型假性醛固酮减少症肾型的日本家族中盐皮质激素受体基因的一种新型错义突变。
J Clin Endocrinol Metab. 2000 Dec;85(12):4690-4. doi: 10.1210/jcem.85.12.7078.
3
Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.一个土耳其家庭中的常染色体显性1型假性醛固酮增多症与人类盐皮质激素受体基因中的一种新型无义突变相关。
J Clin Endocrinol Metab. 2004 May;89(5):2150-2. doi: 10.1210/jc.2003-031555.
4
Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.1型假性醛固酮减少症基因异质性的证据:在1例散发性病例中鉴定出人盐皮质激素受体的新突变,而在2个常染色体显性家族中未发现突变。
J Clin Endocrinol Metab. 2001 May;86(5):2056-9. doi: 10.1210/jcem.86.5.7449.
5
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.盐皮质激素受体基因突变导致常染色体显性遗传I型假性醛固酮减少症。
Nat Genet. 1998 Jul;19(3):279-81. doi: 10.1038/966.
6
Exclusion of the locus for autosomal recessive pseudohypoaldosteronism type 1 from the mineralocorticoid receptor gene region on human chromosome 4q by linkage analysis.
J Clin Endocrinol Metab. 1995 Nov;80(11):3341-5. doi: 10.1210/jcem.80.11.7593448.
7
Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.常染色体显性遗传性1型假性醛固酮减少症非相关家族中R947X突变的复发:盐皮质激素受体基因突变热点的证据
J Clin Endocrinol Metab. 2006 Sep;91(9):3671-5. doi: 10.1210/jc.2006-0605. Epub 2006 Jun 6.
8
Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.在一个患有常染色体显性遗传性1型假性醛固酮减少症的德国家庭中,鉴定出人类盐皮质激素受体基因的一种新突变:进一步证明明显的个体间临床异质性。
J Clin Endocrinol Metab. 2003 Apr;88(4):1683-6. doi: 10.1210/jc.2002-021556.
9
A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.1型假性醛固酮减少症肾脏型中盐皮质激素受体基因的一种新型无义突变。
J Pediatr Endocrinol Metab. 2009 Jan;22(1):91-5. doi: 10.1515/jpem.2009.22.1.91.
10
Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.阐明导致常染色体显性遗传性1型假性醛固酮减少症的NR3C2突变体的潜在分子发病机制。
J Clin Endocrinol Metab. 2006 Nov;91(11):4552-61. doi: 10.1210/jc.2006-1161. Epub 2006 Sep 5.

引用本文的文献

1
Renal pseudohypoaldosteronism type 1-an adult case series including a novel gene variant.1型肾性假性醛固酮减少症——一个包括新型基因变异的成人病例系列
Endocrine. 2025 Mar;87(3):1285-1290. doi: 10.1007/s12020-024-04120-8. Epub 2024 Nov 29.
2
The multifaceted mineralocorticoid receptor.多功能盐皮质激素受体
Compr Physiol. 2014 Jul;4(3):965-94. doi: 10.1002/cphy.c130044.
3
Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.常染色体显性遗传假性醛固酮减少症 1 型伴 MR 基因新剪接位点突变。
BMC Nephrol. 2009 Nov 14;10:37. doi: 10.1186/1471-2369-10-37.